
Premier Inc. ProvideGx™ Program Partners with Fresenius Kabi to Secure the Supply of Sedation Drug Essential for COVID-19 Care
Published on July 13, 2020
The partnership will help stabilize the long-term supply of propofol, a medication vital for COVID-19 patient care.